Eeshan Khandekar, M.Sc., is a Research Associate with the Forum on Drug Discovery, Development, and Translation. Prior to joining the Forum, Eeshan worked on two consensus studies on the Board on Global Health: 1) Global Health and the Future of the United States, and 2) Improving the Quality of Health Care Globally. These studies sought to inform U.S. global health policy and create an agenda for health care quality improvement in low- and middle-income countries, respectively. In both studies, he provided technical research support, supported report writing, and facilitated the execution of dissemination activities. Prior to joining the National Academies, Eeshan worked on multiple projects related to the CDC’s Global Health Security Agenda, global health R&D in the U.S., and health workforce development in Nigeria. Through these positions, he worked closely with the CDC, the Global Health Technology Council, and a Nigerian-based civil society organization. Concurrent to these positions, Eeshan also had the opportunity work with the Clinical Trials Transformation Initiative to conduct policy analysis on telemedicine use, reimbursement, and malpractice to inform the viability of mobile clinical trials. Earlier in his career, Eeshan conducted a program evaluation on Zanzibar’s malaria surveillance system to support the region’s goal of achieving malaria elimination. Eeshan holds a B.A. in Public Policy from The University of North Carolina at Chapel Hill and a M.Sc. in Global Health from Duke University.